ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
USA - NASDAQ:ICUI - US44930G1076 - Common Stock
140.16 USD
+10.49 (+8.09%)
140.16 USD
0 (0%)
Taking everything into account, ICUI scores 4 out of 10 in our fundamental rating. ICUI was compared to 189 industry peers in the Health Care Equipment & Supplies industry. ICUI has only an average score on both its financial health and profitability. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
In multiple years ICUI reported negative net income over the last 5 years.
ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.90%, ICUI is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
The Return On Equity of ICUI (-1.75%) is better than 70.90% of its industry peers.
ICUI has a better Return On Invested Capital (2.81%) than 70.90% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 9.12%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROIC | 2.81% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
Looking at the Operating Margin, with a value of 5.43%, ICUI is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
ICUI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 35.84%, ICUI is not doing good in the industry: 70.90% of the companies in the same industry are doing better.
ICUI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
ICUI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICUI has more shares outstanding
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 2.09. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
ICUI's Altman-Z score of 2.09 is fine compared to the rest of the industry. ICUI outperforms 61.90% of its industry peers.
ICUI has a debt to FCF ratio of 26.58. This is a negative value and a sign of low solvency as ICUI would need 26.58 years to pay back of all of its debts.
ICUI has a better Debt to FCF ratio (26.58) than 68.78% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that ICUI is somewhat dependend on debt financing.
The Debt to Equity ratio of ICUI (0.63) is worse than 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.37
WACC7.53%
2.3 Liquidity
ICUI has a Current Ratio of 2.44. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.44, ICUI perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
A Quick Ratio of 1.17 indicates that ICUI should not have too much problems paying its short term obligations.
The Quick ratio of ICUI (1.17) is worse than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.14% over the past year.
Measured over the past years, ICUI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.28% on average per year.
The Revenue has been growing slightly by 5.44% in the past year.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
3.2 Future
ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.18% yearly.
The Revenue is expected to grow by 1.96% on average over the next years.
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.61 indicates a rather expensive valuation of ICUI.
ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 83.60% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.83. ICUI is valued slightly cheaper when compared to this.
ICUI is valuated rather expensively with a Price/Forward Earnings ratio of 17.07.
Based on the Price/Forward Earnings ratio, ICUI is valued cheaply inside the industry as 84.66% of the companies are valued more expensively.
ICUI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 32.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.61 | ||
| Fwd PE | 17.07 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaper than 84.13% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 68.51 | ||
| EV/EBITDA | 12.6 |
4.3 Compensation for Growth
ICUI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 15.91% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y14.9%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
140.16
+10.49 (+8.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners113.8%
Inst Owner Change-0.44%
Ins Owners0.98%
Ins Owner Change-1.3%
Market Cap3.46B
Revenue(TTM)2.38B
Net Income(TTM)-36.95M
Analysts83.33
Price Target177.68 (26.77%)
Short Float %5.35%
Short Ratio4.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.5%
Min EPS beat(2)31.74%
Max EPS beat(2)37.25%
EPS beat(4)4
Avg EPS beat(4)33.31%
Min EPS beat(4)24.67%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)30.18%
EPS beat(12)12
Avg EPS beat(12)24.5%
EPS beat(16)15
Avg EPS beat(16)18.53%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.09%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)-0.81%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)-2.02%
PT rev (3m)-7.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)0%
EPS NY rev (3m)5.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.61 | ||
| Fwd PE | 17.07 | ||
| P/S | 1.46 | ||
| P/FCF | 68.51 | ||
| P/OCF | 24.93 | ||
| P/B | 1.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.6 |
EPS(TTM)7.96
EY5.68%
EPS(NY)8.21
Fwd EY5.86%
FCF(TTM)2.05
FCFY1.46%
OCF(TTM)5.62
OCFY4.01%
SpS96.09
BVpS85.69
TBVpS-3.41
PEG (NY)1.21
PEG (5Y)N/A
Graham Number123.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROCE | 3.56% | ||
| ROIC | 2.81% | ||
| ROICexc | 3.06% | ||
| ROICexgc | 9.06% | ||
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% | ||
| FCFM | 2.13% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 42.51% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 41.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.09 |
F-Score7
WACC7.53%
ROIC/WACC0.37
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
EBIT growth 1Y118.78%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year37.73%
EBIT Next 3Y15.54%
EBIT Next 5Y10.05%
FCF growth 1Y216.11%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y243.63%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 14.6% in the next year.